RNA viruses as virotherapy agents
- PMID: 12522435
- DOI: 10.1038/sj.cgt.7700535
RNA viruses as virotherapy agents
Abstract
RNA viruses are rapidly emerging as extraordinarily promising agents for oncolytic virotherapy. Integral to the lifecycles of all RNA viruses is the formation of double-stranded RNA, which activates a spectrum of cellular defense mechanisms including the activation of PKR and the release of interferon. Tumors are frequently defective in their PKR signaling and interferon response pathways, and therefore provide a relatively permissive substrate for the propagation of RNA viruses. For most of the oncolytic RNA viruses currently under study, tumor specificity is either a natural characteristic of the virus, or a serendipitous consequence of adapting the virus to propagate in human tumor cell lines. Further refinement and optimization of these oncolytic agents can be achieved through virus engineering. This article provides a summary of the current status of oncolytic virotherapy efforts for seven different RNA viruses, namely, mumps, Newcastle disease virus, measles virus, vesicular stomatitis virus, influenza, reovirus, and poliovirus.
Similar articles
-
[Oncolytic viruses for genetic therapy of gastrointestinal tumors].Z Gastroenterol. 2003 Jul;41(7):667-74. doi: 10.1055/s-2003-40543. Z Gastroenterol. 2003. PMID: 12858239 Review. German.
-
Reovirus - possible therapy of cancer.Neoplasma. 2006;53(6):457-62. Neoplasma. 2006. PMID: 17167712 Review.
-
Natural and genetically engineered viral agents for oncolysis and gene therapy of human cancers.Arch Immunol Ther Exp (Warsz). 2008 Dec;56 Suppl 1:3s-59s. doi: 10.1007/s00005-008-0047-9. Epub 2008 Dec 23. Arch Immunol Ther Exp (Warsz). 2008. PMID: 19104757 Review.
-
Oncolytic vaccinia virus: from bedside to benchtop and back.Curr Opin Mol Ther. 2008 Aug;10(4):387-92. Curr Opin Mol Ther. 2008. PMID: 18683104
-
Oncolytic viruses for the treatment of cancer: current strategies and clinical trials.Drug Discov Today. 2004 Sep 1;9(17):759-68. doi: 10.1016/S1359-6446(04)03221-0. Drug Discov Today. 2004. PMID: 15450242 Review.
Cited by
-
Pro-inflammatory cytokine/chemokine production by reovirus treated melanoma cells is PKR/NF-κB mediated and supports innate and adaptive anti-tumour immune priming.Mol Cancer. 2011 Feb 21;10:20. doi: 10.1186/1476-4598-10-20. Mol Cancer. 2011. PMID: 21338484 Free PMC article.
-
Oncolytic Viral Therapy for Glioma by Recombinant Sindbis Virus.Cancers (Basel). 2023 Sep 27;15(19):4738. doi: 10.3390/cancers15194738. Cancers (Basel). 2023. PMID: 37835433 Free PMC article.
-
A hyperfusogenic F protein enhances the oncolytic potency of a paramyxovirus simian virus 5 P/V mutant without compromising sensitivity to type I interferon.J Virol. 2008 Oct;82(19):9369-80. doi: 10.1128/JVI.01054-08. Epub 2008 Jul 30. J Virol. 2008. PMID: 18667520 Free PMC article.
-
Strategies to Develop Potent Oncolytic Viruses and Enhance Their Therapeutic Efficacy.JCO Precis Oncol. 2021 Apr 27;5:PO.21.00003. doi: 10.1200/PO.21.00003. eCollection 2021. JCO Precis Oncol. 2021. PMID: 34250395 Free PMC article. Review.
-
Generation of measles virus with a segmented RNA genome.J Virol. 2006 May;80(9):4242-8. doi: 10.1128/JVI.80.9.4242-4248.2006. J Virol. 2006. PMID: 16611883 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical